Virtus ETF Advisers LLC Aptinyx Inc. Transaction History

Virtus ETF Advisers LLC

  • $196 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 13, 2019
SELL
$2.95 - $4.38 $36,659 - $54,430
-12,427 Closed
0 $0
Q1 2019

May 14, 2019
SELL
$3.99 - $19.33 $5,897 - $28,569
-1,478 Reduced 10.63%
12,427 $50,000
Q4 2018

Feb 05, 2019
BUY
$16.15 - $28.93 $224,565 - $402,271
13,905 New
13,905 $230,000

About Aptinyx Inc.

APTX Quotes by TradingView
  • Ticker APTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,715,696
  • Description
  • Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...
More about APTX
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email